Physician profile
Mitch D Hulbert
NPI 1518307248
$96,275.62
in general payments reported to CMS, 2019-2025
23 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,514 · 2020: $243 · 2021: $1,739 · 2022: $4,839 · 2023: $26K · 2024: $48K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $68K · Travel and Lodging: $13K · Food and Beverage: $4,639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $68,037.50 |
| Travel and Lodging | $13,263.72 |
| Food and Beverage | $4,639.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $81,852.44 | 2019-2025 | Prostep, Prostep Mica, Prophecy |
| Mimedx Group, INC. | $8,692.50 | 2024 | |
| Medshape, INC. | $3,740.70 | 2022 | |
| Trilliant Surgical LLC. | $540.53 | 2022 | |
| Surgenex LLC | $304.95 | 2025 | Renograft, Pellograft, Surgraft |
| Smith+Nephew, INC. | $218.90 | 2024-2025 | Grafix Pl, Oasis |
| Globus Medical, INC. | $171.25 | 2025 | Senza |
| Treace Medical Concepts, INC. | $150.30 | 2023 | |
| Horizon Therapeutics Plc | $124.97 | 2019 | |
| Biotissue Holdings INC. | $121.42 | 2022 | |
| Osiris Therapeutics INC. | $84.94 | 2019 | |
| Integra Lifesciences Corporation | $60.95 | 2019 | |
| Paragon 28, INC. | $48.82 | 2022 | |
| Exactech, INC. | $25.28 | 2025 | |
| Depuy Synthes Sales INC. | $22.99 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $21.97 | 2024 | Senza |
| Paratek Pharmaceuticals, INC. | $21.01 | 2025 | Nuzyra |
| Encore Medical, LP | $20.55 | 2021 | |
| Medtronic, INC. | $17.29 | 2024 | Intellis Adaptivestim |
| Medline Industries LP | $15.49 | 2025 | |
| Wright Medical Technology, INC. | $11.13 | 2019 | |
| Orthofix Medical, INC. | $7.24 | 2025 | Physio-Stim |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$54,630.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitch Hulbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.